-
Signature
-
/s/Nicole Daniel, Attorney in Fact
-
Issuer symbol
-
LPX
-
Transactions as of
-
02 Feb 2026
-
Net transactions value
-
-$2,477,206
-
Form type
-
4
-
Filing time
-
04 Feb 2026, 11:40:13 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Southern William Bradley |
Chief Executive Officer, Director |
1610 WEST END AVENUE, SUITE 200, NASHVILLE |
/s/Nicole Daniel, Attorney in Fact |
04 Feb 2026 |
0001549626 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
LPX |
Common Stock |
Sale |
$602,933 |
-7,080 |
-1.4% |
$85.16 |
482,135 |
02 Feb 2026 |
Direct |
F1, F2 |
| transaction |
LPX |
Common Stock |
Sale |
$60,123 |
-700 |
-0.15% |
$85.89 |
481,435 |
03 Feb 2026 |
Direct |
F1, F3 |
| transaction |
LPX |
Common Stock |
Sale |
$296,050 |
-3,406 |
-0.71% |
$86.92 |
478,029 |
03 Feb 2026 |
Direct |
F1, F4 |
| transaction |
LPX |
Common Stock |
Sale |
$520,061 |
-5,930 |
-1.2% |
$87.70 |
472,099 |
03 Feb 2026 |
Direct |
F1, F5 |
| transaction |
LPX |
Common Stock |
Sale |
$878,498 |
-9,893 |
-2.1% |
$88.80 |
462,206 |
03 Feb 2026 |
Direct |
F1, F6 |
| transaction |
LPX |
Common Stock |
Sale |
$47,763 |
-532 |
-0.12% |
$89.78 |
461,674 |
03 Feb 2026 |
Direct |
F1, F7 |
| transaction |
LPX |
Common Stock |
Sale |
$65,834 |
-726 |
-0.16% |
$90.68 |
460,948 |
03 Feb 2026 |
Direct |
F1, F8 |
| transaction |
LPX |
Common Stock |
Sale |
$5,945 |
-65 |
-0.01% |
$91.46 |
460,883 |
03 Feb 2026 |
Direct |
F1, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: